Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 14 September 2026.

Announcements

76

Total raised

£915M

disclosed amounts

Grant
£490K

The biotechnology startup received the grant to scale up manufacturing processes for green cosmetic compounds.

"This collaboration with Teesside University, led by Associate Professor Dr. M. Safwan Akram an expert in Synthetic biology and BiBerChem Research led by Professor Bernard Golding a Synthetic Organic Chemist brings together our complementary strengths and expertise, and we are excited to see the results of our joint efforts in this important area"
— Olusola Idowu, CEO
Grant
£6.6M

The funding was awarded by the Center for Connected Autonomous Vehicles to back the Hub2Hub hydrogen vehicle project.

"Our market analysis indicates that the commercial vehicle segments such as haulage are where we will see autonomous vehicle technology first used in large scale deployments. Hub2Hub is a perfect showcase of what the advanced version of our CAVstar Automated Drive System can achieve. Combining SAE Level 4 autonomous driving with tele-operation to deliver safer and more efficient vehicle operations."
— Jim Hutchinson, CEO
Grant
£1.0M

The medtech startup will use the fresh capital to bring its pharmacist digitisation software to market.

"Using just an NHS number, we can create personalised, contextualised insights that will help people stay well. We’re so grateful to receive this additional Innovate UK backing so we can scale this application of our software and move a step closer towards creating a single source of truth for medicines data in the UK."
— Issa Dasu-Patel, CEO
Grant
$14.2M

The grant funding will support the development and launch of a molecular tuberculosis testing system for developing countries.

"The advancement of our TB molecular test signifies an important step forward in LumiraDx’s mission to increase access to accurate and affordable testing worldwide as well as an important step forward in our molecular testing technology. The support from the Gates Foundation is critical in our development of the TB test and ensuring it reaches communities where access to testing is most challenged. The availability of these immediate results can be game changing."
— Ron Zwanziger, CEO